Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of HK-660S in Primary Sclerosing Cholangitis
KCT0006590Phase 2Completed
- Sponsor
- Curome Biosciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapachone in Primary Sclerosing Cholangitis (PSC), sponsored by Curome Biosciences. Started Nov 2021; status: completed.
02
Drugs
lapachone
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on KCT0006590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006590.